Cancer Biomarker Market Size, Scope 2022-2028
December 1, 2022 ⚊ 1 Min read ⚊ Views 65 ⚊ BUSINESS
The global cancer biomarkers market size was valued at USD 15.06 billion in 2021 and expected to reach USD 31.53 billion by 2028 witnessing a CAGR rate of 11.5% during the forecast period 2022-2028. Cancer biomarkers are biological chemicals created in response to cancer by tumor cells or human tissues, which are subsequently analyzed and examined as indicators of malignant activities in the body. Cancer biomarkers are widely employed in the diagnosis and treatment of cancer patients. Biomarkers are employed in the follow-up monitoring and early diagnosis of suspected recurring illness in cancer patients who have had curative surgery. Furthermore, the use of molecular biomarkers as part of normal diagnostic testing is a constant advancement in cancer diagnosis. The utilization of DNA, RNA, microRNAs, and proteins in cancer detection involves molecular changes.
